Polysaccharide and lipid components of Bacteroides thetaiotaomicron lipopolysaccharide as stimulators of endothelial adhesion molecule expression

Abstract

Bacteroides thetaiotaomicron , a Gram-negative anaerobic rod and a member of the Bacteroides fragilis group (BFG) causes many systemic and local infections in humans, most of which are endogenous and suppurative. The microorganism produces two high-molecular weight, carbohydrate-containing cell-surface antigens, both of which have been implicated as virulence factors for this organism; these consist of lipopolysaccharide (LPS) and capsular polysaccharide (CPS). Adhesion molecules ICAM-1, VCAM-1 and E-selectin can be stimulated to be expressed on the surface of endothelial cells (ECs) by a variety of mediators of inflammation. The aim of this study was to assess the ability of polysaccharide (PS) and lipid (lipid A) components of three B. thetaiotaomicron LPS preparations to induce adhesion molecule expression on the surface of human vascular endothelial cells. The HMEC-1 cell line has been employed along with ELISA assays to examine the relative activity of B. thetaiotaomicron LPS. ELISA was performed using monoclonal mouse anti-human ICAM-1, VCAM-1 and E-selectin antibodies. The lipid A moieties of the three LPS revealed the ability to stimulate ICAM-1, VCAM-1 and E-selectin on endothelial cells. Their relative activities were similar and stronger than the biological activity of the lipid A-depleted polysaccharide (PS) components of LPS that were, nevertheless, significantly above background levels. In contrast, the PS moiety of LPS extracted from a reference strain B. thetaiotaomicron NCTC 10582 was totally unable to induce the expression of any adhesion molecule under investigation. The lipid A of B. thetaiotaomicron LPS is, therefore, and probably not unexpectedly, involved in the stimulation of adhesion molecules that are expressed on HMEC-1 to a greater extent than the PS moiety. Importantly, however, the PS components of the two LPS preparations tested manifest a weak but, nevertheless, significant activity in this process. It is possible that the PS moiety may modify the immunobiological effects of the complete LPS molecule.

References

Finegold SM Anaerobic infections in humans: an overview. Anaerobe 1995; 1: 3—9.

Gorbach SL , Bartlett JG Anaerobic infections. N Engl J Med 1974; 90: 1174—1184.

Hoffler U. Anaerobic bacteria in human medicine. Labmedica 1987; 4: 21—26.

Moore Wec , Cato EP , Holdeman LV Some current topics in intestinal bacteriology. Am J Clin Nutr 1978; 31: S33—S42.

Werner H. Differentiation and medical importance of saccharolytic intestinal Bacteroides . Drug Res 1974; 24: 340—343.

Hofstad T. Virulence factors in anaerobic bacteria. Eur J Clin Microbiol Infect Dis 1992; 11: 1044—1048.

Kasper DL Virulence factors of anaerobic bacteria: an overview. Rev Infect Dis 1979; 1: 246—247.

Pruzzo C. , Guzman CA , Danielli B. Incidence of hemagglutination activity among pathogenic and non-pathogenic Bacteroides fragilis strains and role of capsule and pili in HA and adherence . FEMS Microbiol Lett 1989; 59: 113—118.

van Doorn J. , Mooi FR , Verweij-van Vught Amjj , MacLaren DM Characterization of fimbriae from Bacteroides fragilis. Microb Pathog 1987; 3: 87—95.

10.

Hofstad T. Pathogenicity of anaerobic Gram-negative rods: possible mechanisms. Rev Infect Dis 1984; 6: 189—199.

11.

Kasper DL The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition. J Infect Dis 1976 ; 133: 79—87.

12.

Onderdonk AB , Kasper DL , Cisneros RL , Bartlett JG The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. J Infect Dis 1977; 136: 82—89.

13.

Meisel-Mikolajczyk F. , Rokosz A. , Rouyan GS Influence of clindamycin on endotoxin and enterotoxin release from Bacteroides fragilis. Alpe Adria Microbiol J 1997; 6: 113—117.

14.

Holst O. , Ulmer AJ , Brade H. , Flad H-D. , Rietschel ET Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol 1996; 16: 83—104.

15.

Meisel-Mikolajczyk F. , Rokosz A. , Kaca W. The cell-surface antigens of Bacteroides thetaiotaomicron . Eur J Epidemiol 1989; 5: 486—496.

16.

Kaca W. The role of polysaccharide part of Proteus mirabilis lipopolysaccharides in interaction with human cells and proteins. Post Mikrobiol 1996; 35: 503—507.

17.

Kasper DL Chemical and biological characterization of the lipopolysaccharide of Bacteroides fragilis subspecies fragilis. J Infect Dis 1976; 134: 59—66.

18.

Lindberg AA , Weintraub A. , Zahringer U. , Rietschel ET Structure-activity relationship in lipopolysaccharides of B. fragilis. Rev Infect Dis 1990; 12 (Suppl. 21): 133—141.

19.

Mikolajczyk E. , Rokosz A. , Sawicka-Grzelak A. , Meisel-Mikolajczyk F. The toxicity of Bacteroides fragilis endotoxins before and after removal of nucleic compounds. Acta Microbiol Polon 1981; 30: 97—100.

20.

Rokosz A. , Kruszewska D. , Rouyan GS , Meisel-Mikolajczyk F. Detection of Bacteroides fragilis endotoxin and enterotoxin in culture medium . Med Dosw Mikrobiol 1997, 49: 61—67.

21.

Rokosz A. , Marciniak-Rusek A. , Aleksandrowicz J. , Meisel-Mikolajczyk F. LAL test for quantitative determination of Bacteroides fragilis endotoxin . Med Dosw Mikrobiol 1997; 49: 157—164.

22.

Sveen K. The capacity of lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella to produce skin inflammation and the local and generalized Shwartzman reaction in rabbits. J Periodont Res 1977; 12: 340—350.

23.

Hofstad T. , Skaug N. , Sveen K. Stimulation of B lymphocytes by lipopolysaccharides from anaerobic bacteria . Clin Infect Dis 1993; 16 (Suppl. 4): S200—S202.

24.

Weintraub A. , Zahringer U. , Wollenweber H-W. , Seydel U. , Rietschel ET Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem 1989; 183: 425—431.

25.

Babb JL , Cummins CS Encapsulation of Bacteroides species. Infect Immun 1978; 19: 1088-1091.

26.

Meisel-Mikolajczyk F. , Galkowska H. The immunochemical investigations of six Bacteroides serotypes. Acta Microbiol Polon 1976, 25: 389—399.

27.

Strohm H. , Payne CM , Ryan KJ Demonstration of Bacteroides capsules by light microscopy and ultrastructural cytochemistry. Am J Clin Pathol 1983; 79: 591—597.

28.

Wollenweber H-W. , Rietschel ET , Hofstad T. , Weintraub A. , Lindberg AA Nature, type of linkage, quantity and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol 1980; 144: 898—903.

29.

Rokosz A. , Grzybowski J. , Kaca W. , Meisel-Mikolajczyk F. The cell-surface components of Bacteroides thetaiotaomicron as coating antigens in ELISA test. Acta Microbiol Polon 1989; 38: 285—291.

30.

Rokosz A. , Kruszewska D. , Rumin W. , Meisel-Mikolajczyk F. The toxicity of Bacteroides thetaiotaomicron cell-surface antigens to chicken embryos. Acta Microbiol Polon 1990; 39: 211—214.

31.

Rokosz A. , Meisel-Mikolajczyk F. Application of the cell-surface antigens of Bacteroides thetaiotaomicron in the passive hemagglutination test and in the inhibition of passive hemagglutination . Med Dosw Mikrobiol 1995; 47: 189—195.

32.

Carlos TM , Harlan JM Leukocyte-endothelial adhesion molecules. Blood 1994; 84: 2068—2101.

33.

Górski A. The role of cell adhesion molecules in immunopathology. Immunol Today 1994; 15: 251—255.

34.

Springer TA Adhesion receptors of the immune system. Nature 1990; 346: 425—434.

35.

Lynn WA , Golenbock DT Lipopolysaccharide antagonists. Immunol Today 1992; 13: 271—276.

36.

Janiak MK

Role of cell adhesion receptors in tumor metastasis. Centr

Eur J Immunol 1996; 21 (Suppl. 1): S63—S83.

37.

Rokosz A. , Meisel-Mikolajczyk F. , Malchar C. , Nowaczyk M. , Górski A. The expression of adhesion molecules induced by Bacteroides thetaiotaomicron cell-surface antigens. Immunologist 1997; 5 (Suppl. 1): 51.

38.

Dowell Jr VR , Hawkins TM Laboratory Methods in Anaerobic Bacteriology. DEHW Atlanta : CDC Laboratory Manual, 1974.

39.

Westphal O. , Jann K. Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965; 5: 83—91.

40.

Gmeiner J. The isolation of two different lipopolysaccharide fractions from various Proteus mirabilis strains. Eur J Biochem 1975; 58: 621—626.

41.

Weintraub A. , Zahringer U. , Lindberg AA Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343. Eur J Biochem 1985; 151: 657—661.

42.

Lassalle P. , Gosset P. , Delneste Y. et al. Modulation of adhesion molecule expression on endothelial cells during the late asthmatic reaction: role of macrophage-derived tumour necrosis factor-alpha. Clin Exp Immunol 1993; 94: 105—110.

43.

Lee KH , Lawley TJ , Xu Y. , Swerlick RA VCAM-1-, ELAM-1-, and ICAM-1-independent adhesion of melanoma cells to cultured human dermal microvascular endothelial cells. J Invest Dermatol 1992; 98: 79—85.

44.

Swerlick RA , Lee KH , Li L-J. , Sepp NT , Caughman SW , Lawley TJ Regulation of vascular cell adhesion molecule 1 on human dermal microvascular endothelial cells. J Immunol 1992; 149: 698—705.

45.

Meisel-Mikolajczyk F. , Rouyan GS , Dybowska B. , Górski A. Human T cell adhesion to endothelium stimulated by membrane components extracted from strains of Bacteroides vulgatus (member of B. fragilis group). Arch Immunol Ther Exp 1993; 41: 129—131.